Coherus Oncology Inc (CHRS)

Depreciation & Amortization

$862.00K

Quarterly · Period ending: · USD

CHRS logo

CHRS Depreciation & Amortization

Latest reported$862.00K
CHRS Quarterly Depreciation & Amortization ($96.00K → $862.00K)
High-resolution chart · PNG

CHRS depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
862,000
881,000
896,000
966,000
1,016,000
1,046,000
1,033,000
1,549,000
1,187,000
1,507,000
1,063,000
899,000
880,000
949,000
1,050,000
995,000
887,000
767,000
1,425,000
892,000
877,000
849,000
840,000
693,000
748,000
607,000
1,055,000
839,000
674,000
691,000
613,000
798,000
902,000
922,000
926,000
770,000
837,000
865,000
797,000
753,000
729,000
717,000
601,000
636,000
400,000
232,000
235,000
192,000
131,000
116,000
108,000
101,000
99,000
96,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.